Fluocortolone

Oral
Corticosteroid therapy

Topical/Cutaneous
Corticosteroid-responsive dermatoses

Systemic infection; widespread plaque psoriasis, untreated fungal or viral skin lesions; infants <1 yr. Rosacea; perioral dermatitis and acne vulgaris.

Adrenal suppression (growth retardation possibly irreversible); elderly, adolescents, child; history of tuberculosis, hypertension, recent MI; hepatic and renal failure; diabetes mellitus; osteoporosis; glaucoma, corneal perforation; severe affective disorders, epilepsy; peptic ulcer; hypothyroidism; history of steroid myopathy; pregnancy, lactation. Avoid contact with eyes.

Severe pituitary-adrenal-axis suppression, Cushing's syndrome, worsening of untreated infections, thinning of the skin, irreversible striae atrophicae and telangiectasia, dermatitis, acne, mild depigmentation, atrophy.
Potentially Fatal: Hypersensitivity.

Description:
Mechanism of Action: Fluocortolone and its esters are corticosteroids used topically for their glucocorticoid activity.

Topical Corticosteroids